FPR3 reprograms glycolytic metabolism and stemness in gastric cancer via calcium-NFATc1 pathway
Cancer Letters · 2024
DOI: 10.1016/j.canlet.2024.216841 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Lingzhi Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China; Guangdong Provincial Key Laboratory of Precis…. Hauptthemen laut MEDLINE: Cell Proliferation, Glycolysis, Neoplastic Stem Cells, Signal Transduction. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aerobic glycolysis accelerates tumor proliferation and progression, and inhibitors or drugs targeting abnormal cancer metabolism have been developing. Cancer stem-like cells (CSCs) significantly contribute to tumor initiation, metastasis, therapy resistance, and recurrence. Formyl peptide receptor 3 (FPR3), a member of FPR family, involves in inflammation, tissue repair, and angiogenesis. However, studies in exploring the regulatory mechanisms of aerobic glycolysis and CSCs by FPR3 in gastric cancer (GC) remain unknown. Here, we demonstrated that overexpressed FPR3 suppressed glycolytic capacity and stemness of tumor cells, then inhibited GC cells proliferation. Mechanistically, FPR3 impeded cytoplasmic calcium ion flux and hindered nuclear factor of activated T cells 1 (NFATc1) nuclear translocation, leading to the transcriptional inactivation of NFATc1-binding neurogenic locus notch homolog protein 3 (NOTCH3) promoter, subsequently obstructing NOTCH3 expression and the AKT/mTORC1 signaling pathway, and ultimately downregulating glycolysis. Additionally, NFATc1 directly binds to the sex determining region Y-box 2 (SOX2) promoter and modifies stemness in GC. In conclusion, our work illustrated that FPR3 played a negative role in GC progression by modulating NFATc1-mediated glycolysis and stemness in a calcium-dependent manner, providing potential insights into cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China; Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Me…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, L., Mao, X., Yu, X., Su, J., Li, Z., Chen, Z., Ren, Y., Huang, H., Wang, W., Zhao, C., & Hu, Y. (2024). FPR3 reprograms glycolytic metabolism and stemness in gastric cancer via calcium-NFATc1 pathway. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.216841
Vancouver
Wang L, Mao X, Yu X, Su J, Li Z, Chen Z, et al. FPR3 reprograms glycolytic metabolism and stemness in gastric cancer via calcium-NFATc1 pathway. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.216841
BibTeX
@article{Wang2024,
author = {Wang, Lingzhi and Mao, Xinyuan and Yu, Xiang and Su, Jin and Li, Zhenyuan and Chen, Zhian and Ren, Yingxin and Huang, Huilin and Wang, Weisheng and Zhao, Cuiyin and Hu, Yanfeng},
title = {FPR3 reprograms glycolytic metabolism and stemness in gastric cancer via calcium-NFATc1 pathway},
journal = {Cancer Letters},
year = {2024},
doi = {10.1016/j.canlet.2024.216841}
}
EUVIMED